Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Aclaris Therapeutics Inc., 3 years.
Aclaris Therapeutics Inc.
Director · CEO
Aldeyra Therapeutics Inc.
Director
Chief executive roles
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 3, 2026 | Aclaris Therapeutics Inc. | Option exercise | +63,475 | — | — |
| Feb 3, 2026 | Aclaris Therapeutics Inc. | Shares withheld for tax | −18,611 | $3.47 | $64,580 |
| Jan 2, 2026 | Aclaris Therapeutics Inc. | Option exercise | +29,150 | — | — |
| Jan 2, 2026 | Aclaris Therapeutics Inc. | Shares withheld for tax | −9,952 | $2.88 | $28,662 |
| May 1, 2025 | Aclaris Therapeutics Inc. | Option exercise | +9,467 | — | — |
| May 1, 2025 | Aclaris Therapeutics Inc. | Shares withheld for tax | −2,975 | $1.38 | $4,106 |
| Apr 1, 2025 | Aclaris Therapeutics Inc. | Option exercise | +9,467 | — | — |
| Apr 1, 2025 | Aclaris Therapeutics Inc. | Shares withheld for tax | −3,042 | $1.48 | $4,502 |
| Mar 1, 2025 | Aclaris Therapeutics Inc. | Option exercise | +9,466 | — | — |
| Mar 1, 2025 | Aclaris Therapeutics Inc. | Shares withheld for tax | −3,277 | $1.99 | $6,521 |
| Feb 1, 2025 | Aclaris Therapeutics Inc. | Option exercise | +9,467 | — | — |
| Feb 1, 2025 | Aclaris Therapeutics Inc. | Shares withheld for tax | −3,559 | $2.48 | $8,826 |
| Jan 2, 2025 | Aclaris Therapeutics Inc. | Option exercise | +29,149 | — | — |
| Jan 2, 2025 | Aclaris Therapeutics Inc. | Shares withheld for tax | −13,532 | $2.48 | $33,559 |
| Jan 1, 2025 | Aclaris Therapeutics Inc. | Option exercise | +9,467 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.